MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020

Date: March 27, 2025
Time: 9:00 am to 5:00 pm*
Location: Westin Sacramento, Monaco II
4800 Riverside Blvd
Sacramento, CA 95822

 

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.

 

Public Comment Instructions

 Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.

Written comment may be sent to the following email address: cmandac@cirm.ca.gov. Please note that letters received less than 48 hours before the meeting may not be distributed until after the meeting.

Members of the public who are listening to the meeting via teleconference and wish to make oral comment will have the opportunity to do so by doing the following: 

• Once we have called for public comment, members of the public are to press *9 if joining by phone or raise a Zoom hand, which will place you in a queue to make your comment.
• Once we call your name you may have up to 3 minutes (specific time dependent on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.

 

YouTube:
https://www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 895 2249 3412
Passcode: 250327

 

Open Session

1. Call to Order
2. Roll Call
3. Chair’s Report
4. Vice-Chair’s Report
5. President’s Report

Consent Calendar

6. Consideration of Minutes from the January 30 ICOC-ARS Meeting
7. Consideration of Appointment of a Member to the Access and Affordability Working Group

Open Session

8. Consideration of Applications Submitted in Response to Clinical Program Announcements (CLIN 1, 2, and 4)
   • Presentation
   • Summaries
9. Consideration of the DISC5 Concept Plan
   • Plenary Documents
     • Presentation
     • Memo
     • Common Requirements and Definitions
   • DISC5 Documents
     • Presentation
     • Concept Plan
10. Consideration of the DISC4 Concept Plan
    • Presentation
    • Concept Plan
11. Consideration of the Preclinical Development Concept Plan
    • Presentation
    • Concept Plan
12. Consideration of Amendments to the CLIN2 Concept Plan
    • Presentation
    • Concept Plan
13. Consideration of Amendments to the Review Process and Grants Working Group Bylaws
    • Presentation
    • Memo: GWG Bylaws
    • Memo: DISC4 and PDEV Presubmission Forms
14. Consideration of the Community Cares Centers of Excellence Concept Plan
    • Presentation
    • Memo
    • Concept Plan
    • Letter to the Board
15. Consideration of Recommendation from Governance Subcommittee Regarding the CIRM Purchasing Policy
    • Presentation
    • Memo: Purchasing Policy
16. Resolution Honoring Larry Goldstein
17. Update from Communications

Closed Session

18. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to Clinical program announcements (Health & Safety Code 125290.30(f) (3) (B) and (C)).
19. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to the Clinical, Translational, and Discovery portfolio. (Health & Safety Code 125290.30(f) (3) (B) and (C)).

Open Session

20. General Comments on ARS Process
21. Public Comment
22. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/.

The Committee may take action on any item listed on this agenda.

*The duration of the meeting is an estimate, only. The meeting may continue beyond this estimated time in order to address the items on this agenda.